Carol Thomas Daily

As surging oil prices and elevated yields trigger a historic market split, traditional defense and industrial sectors are seizing the spotlight.

As the era of cheap capital ends, private equity is tapping veteran operators to drive organic growth. Inside Todd Cooper’s strategic move to the deal team.

Sequel Med Tech’s twiist system just gained FDA clearance for type 2 diabetes, signaling a massive shift in how millions will manage their insulin therapy.

As JetBlue and Aruba celebrate two decades of nonstop flights, we unpack the economic, environmental, and strategic forces shaping modern Caribbean travel.

As the omnichannel jeweler turns 18, it leverages strategic pop-ups and accessible natural diamonds to capture the shifting American consumer market.

A $29 million gift to Sunnybrook Health Sciences Centre accelerates Canada's precision oncology race while highlighting a reliance on private wealth.

A new integration bypasses traditional message brokers, piping factory floor data directly into cloud AI to power digital twins and autonomous manufacturing.

As specialty practices lose millions to mismanaged paper referrals, specialized AI agents are finally dragging the healthcare back office into the modern era.

As Elevate Agency publicly launches its AI infrastructure platform, we examine the lucrative business of selling 'shovels' in the modern AI gold rush.

As the National Academy of Medicine's $1.5M competition concludes, a novel biologic targeting muscle loss challenges how we treat human aging.

Digital fitness enters the clinic. Future's new partnership with BodySpec bundles medical-grade DEXA scans to merge remote coaching with physical diagnostics.

Canyon Partners has appointed Chris Hansen as Partner and CIO, signaling a major shift in how alternative credit funds view technology and AI in underwriting.

As commission structures shift, eXp Realty partners with nonbank giant Newrez to capture mortgage revenue, testing the limits of the end-to-end transaction.

Asahi Kasei Therapeutics begins Phase 2a trials for AIC468, a pioneering RNA-splicing therapy aiming to solve a critical kidney transplant dilemma.

By combining workplace insights with Indeed's massive job marketplace, Glassdoor's new matching tool wants to end job board fatigue and ghosting for good.

CITY JAM's new INDUSTRY.AIFF applies Fortune 5000 venture disciplines to the music industry's most expensive problem: signed artists who never ship.

The 2026 World's 50 Best Bars list reveals a massive geographical rebalancing, with Paris eclipsing London and emerging markets claiming newfound dominance.

As Alpine costs soar, a new index reveals how budget-conscious skiers are trading French slopes for high-value resorts in the Balkans and Scandinavia.

As MeWe integrates Payward's crypto wallets to build a direct-to-consumer economy, the privacy-first network faces the ultimate test of financial compliance.

As Chile Wine Fest debuts in Miami, producers are battling tariffs and 'value' stereotypes to reposition their wines and pisco for the luxury market.